2020 annual financial data
Summit Therapeutics 2020 Operating income
Direct answer
Operating income was -71,646,000 GBP.
Operating income was -71,646,000 GBP and net income was -38,534,681 GBP.
Operating cash flow was -35,337,890 GBP.
Get free Summit Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 628,875 GBP
- Operating income
- -71,646,000 GBP
- Net income
- -38,534,681 GBP
- Operating cash flow
- -35,337,890 GBP